Company intelligence
CenExel
A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes
About CenExel
CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to confidently progress from site selection to study close-out and accelerate life-changing therapies. Get more value from your clinical trials with CenExel.
Verified activity
Signals from CenExel
3 published signals
Presence & Recognition
CenExel featured Dr. Kimball Johnson discussing the evolution of GLP-1 therapies from appetite control and weight loss toward broader metabolic health, systemic protection, and precision medicine.
Reported by CenExel
Research & Knowledge
CenExel Atlanta is currently seeking participants for a clinical research study focused on tobacco harm reduction.
Reported by Leslie Gibbs, CCRP
Presence & Recognition
CenExel is attending the 20th Annual Pain Therapeutics Summit in the San Francisco Bay Area from September 28 to 29, 2026, representing Todd Bertoch, MD, Chief Medical Officer, Pain Research, Josh Rothstein, MD, MS, FACEP, Medical Director/Principal Investigator, and Carol Minoughan, Vice President, Business Development.
Reported by CenExel